Nanjing Xingyin Pharmaceutical Research Co., LTD., established in October 2000, is a wholly-owned holding company of Nanjing Xingyin Pharmaceutical Group Co., LTD., mainly engaged in the development, consulting, transfer and service of proprietary Chinese medicine, chemical medicine, health care products, pharmaceutical technology and pharmaceutical scientific research technology.
Since the establishment of the company, its self-developed drugs include zinc gluconate nasal spray (Strelin), triamcinolone acetonide nasal spray (Strelink), Gegen decoction mixture, compound codeine phosphate oral solution, Zareplon tablets, etc. These drugs are widely used in clinical practice and are highly respected by doctors and patients. At the same time, the company actively declared patented technology, has applied for 17 patents such as Gegen Tang mixture manufacturing process, and obtained 6 authorized patents.
In recent years, Nanjing Xingyin Drug Research Co., Ltd. involved in the development of clinical new drugs, including antihypertensive drugs, hypoglycemic drugs, immune system drugs, ophthalmic drugs, antidepressants, cardiovascular drugs, etc. These products will gradually enter the clinical approval or production procedures, will soon be promoted to the market, so that the majority of clinicians and patients benefit.